The “Neuroprosthetics 2018-2028: Technologies, Forecasts, Players” report has been added to Research and Markets’ offering.
The WHO estimates 360 million people worldwide suffer from some form of disabling hearing loss. Of these, about 1 million in both the United States and the United Kingdom suffer from severe to profound hearing loss. Vision loss is becoming an increasing problem as well. Retinal degenerative diseases such as retinitis pigmentosa (RP) and macular degeneration (MD) affect millions of people every year. Furthermore, the number of people with MD in the United States is projected by the NIH to rise from just under 2 million in 2010 to over 5 million people in 2050.
Neuroprosthetics is a growing field that has the potential to re-engineer a patient’s lost sense of sight and sound. While some devices like cochlear implants have been in existence for decades, continued innovation in this area generates new devices today with increased frequency resolution and durability. Additionally, cochlear implants have served as the basis for the growing field of retinal implants.
Implanted into the retina to replace a patient’s lost rod and cone cells, retinal implants transduce visual information (often gathered by a camera), to the remaining nerve cells in the back of the eye to be sent to and interpreted by the brain. Even still, there are retinal implants that function without cameras, harnessing the pathway of light as it naturally occurs within the eye.
Key Topics Covered:
1. Executive Summary
2. Introduction to Neuroprosthetics
3. Market Forecasts
4. Competitive Interests in Patents & Clinical Trials
5. Competitive Landscape for Neural Probes
6. Competitive Landscape for Cochlear Implants
7. Competitive Landscape for Retinal Implants
8. Competitive Landscape for Neuroprosthetic Limbs
For more information about this report visit https://www.researchandmarkets.com/research/2c6n57/neuroprosthetics